Urjita Sudula’s practice focuses on a wide range of antitrust matters, including merger review, criminal and civil government investigations, and civil litigation.

Urjita has represented clients in high-profile and sophisticated matters, including mergers and acquisitions requiring regulatory approval in numerous jurisdictions, global cartel investigations, and complex antitrust litigation matters in federal and state courts. She advises clients across industries on all aspects of the merger review process, including Second Request investigations, antitrust risk assessments, multijurisdictional filing analysis, and Hart-Scott-Rodino Act compliance.

Urjita joined the firm in 2021 after completing two federal clerkships.

Read More

Notable Experience

  • T-Mobile in its $4.3 billion acquisition of UScellular’s wireless operations and select spectrum assets.

  • FEMSA in the merger of Envoy Solutions and BradyIFS.

  • Google in its $5.4 billion acquisition of Mandiant.

  • Fresenius in its $2.4 billion combination of Fresenius Health Partners, Cricket Health, and InterWell Health to create a kidney disease-focused value-based care company.

  • Varsity Brands in antitrust class and individual actions.

  • Sony Pictures in several acquisitions.

  • Warburg Pincus in several acquisitions.

  • Cushman & Wakefield’s subsidiary, Pinnacle, in multi-district litigation and related investigations into alleged coordination on pricing through AI-based revenue management software.

  • Korean Air in its $1.3 billion acquisition of Asiana Airlines.

  • Multiple non-public grand jury and government investigations relating to alleged antitrust (i.e., price-fixing, market allocation, and bid-rigging) and fraud violations.

See More